Abstract
Immunodeficiency, whether congenital or acquired, increases the risk of certain, but not all, types of cancer. The study of cancer in the HIV-infected population offers a unique opportunity to investigate on an unprecedented large scale the role of the immune system in the onset and growth of tumours.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Human immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses. Vol. 67, Lyon, IARC, 1996.
Biggar RI, Horm J, Goedert JJ, Melbye M: Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 126:578–586, 1987.
Biggar RI, Rosenberg PS, Coté T: Kaposi’s sarcoma and non-Hodgkin’s lymphoma following the diagnosis of AIDS. Int J Cancer 68: 754–758, 1996
Goedert JJ, Coté TR, Virgo P: Spectrum of AIDS-associated malignant disorders. Lancet 351: 1833–1839, 1998
Franceschi S, Dal Maso L, Armani S, et al: Risk of cancer other than Kaposi’s sarcoma and non-Hodgkin’s lymphoma in persons with AIDS in Italy. Br J Cancer 78:966–970, 1998
Grulich AE, Wan X, Law MG, et al: Risk of cancer in people with AIDS. AIDS 13: 839–843,1999
Franceschi S, Geddes M: Epidemiology of classic Kaposi’s sarcoma, with special reference to Mediterranean population. Tumori 81:308–314, 1995
Franceschi S, Dal Maso L, Lo Re A, et al: Trends of Kaposi’s sarcoma at AIDS diagnosis in Europe and the United States, 1987–94. Br J Cancer 76:114–117, 1997
Chang Y, Cesarman E, Pessin MS, et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 265:1865–1869, 1994
Boshoff C: Kaposi’s sarcoma associated herpesvirus. in Newton R, Beral V, Weiss RA (eds): Infections and Human Cancer. Cancer Surveys Vol. 33:157–190, 1999
Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians, and Ugandans with and without Kaposi’s sarcoma. Nat Med 2: 925–928, 1996
Melbye M, Cook PM, Hjalgrim H, et al: Risk factors for Kaposi’s-sarcomaassociated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981–1996. Int J Cancer 77:543–548, 1998
ENAADS European Centre for the Epidemiological Monitoring of AIDS: HIV/AIDS Surveillance in Europe. Quarterly Report No. 60, AIDS Cases Report by 31 December 1998. Saint-Maurice, France, Hôpital National de Saint-Maurice, 1998
Dal Maso L, Franceschi S, Negri E, et al: Trends of AIDS incidence in Europe and the United States. Soz Präventivmed 40:239–265, 1995
Koblin BA, Hessol NA, Zauber AG, et al: Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978–1990. Am J Epidemiol 144: 916–923, 1996
Rabkin CS, Yellin F: Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type I. J Natl Cancer Inst 86:1711–1716, 1994
Lyter DW, Bryant J, Thackeray R, et al: Non-AIDS defining malignancies in the multicenter AIDS cohort study (MACS), 1984–96. J Acquir Immune Defic Syndr Hum Retrovirol 17: A13, 1998 (abstr).
Selik RM, Rabkin, CS: Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 90: 1300–302, 1998
Serraino D, Franceschi S: Kaposi’s sarcoma in children with AIDS in Europe and the United States. Eur J Cancer 32A:650–651, 1996
Dal Maso L, Parazzini F, Lo Re A, et al: Paediatric AIDS incidence in Europe and the USA, 1985–96. J Epidemiol Biostat 4:75–81, 1999
Granovsky MO, Mueller BU, Nicholson HS, et al: Cancer in human immunodeficiency virus-infected children: a case series from the Children’s Cancer Group and the National Cancer Institute. J Clin Oncol 16: 1729–1735, 1998
Wabinga HR, Parkin DM, Wabwire-Mangen F, et al: Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 54: 26–36, 1993
Bassett MT, Chokunonga E, Mauchaza B, et al: Cancer in the African population of Harare, Zimbabwe, 1990–1992. Int J Cancer 63: 29–36, 1995
Newton R, Grulich A, Beral V, et al: Cancer and HIV infection in Rwanda. Lancet i: 1378, 1995 (letter)
Sitas F, Bezwoda WR, Levin V, et al: Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Br J Cancer 75: 1704–1707, 1997
Kinlen L: Immunologic factors, including AIDS, in Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention, 2ndedn. New York, Oxford University Press, 1996, pp 532–545
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr virus and Kaposi’s sarcoma herpesvirus/human herpesvirus 8. Vol. 70, Lyon, IARC, 1997
Franceschi S, Dal Maso L, La Vecchia C: Advance in the epidemiology of HIV-associated non-Hodgkin’s lymphoma and other lymphoid neoplasms. Int J Cancer 83: 481–485, 1999
Coté TR, Biggar RJ, Rosenberg, P, et al: Non-Hodgkin’s lymphoma among people with AIDS: incidence, presentation and public health burden. Int J Cancer 73: 645650, 1997.
Serraino D, Pezzotti P, Dorrucci M, et al: Cancer incidence in a cohort of Human Immunodeficiency Virus seroconverters. Cancer 79: 1004–1008, 1997
Mueller BU: Cancer in children infected with the human immunodeficiency virus. Oncologist 4: 309–317, 1999
Kingma DW, Weiss A, Sorbara L, et al: Is lymphocytic interstitial pneumonitis and early stage of MALT lymphoma in HIV- infected pediatric patients? J Acquir Immune Defic Syndr Hum Retrovirol 14: A54, 1997 (abstr)
Newton R, Ngilimana P-J, Grulich A, et al: Cancer in Rwanda. Int J Cancer 66: 7581, 1996
Serraino D, Carrieri P, Pradier C, et al: Risk of invasive cervical among women with, or at risk for, HIV infection. Int J Cancer 82: 334–337, 1999
Parazzini F, Chatenoud L, La Vecchia C, et al: Determinants of risk of invasive cervical cancer in young women. Br J Cancer, 77, 838–841, 1998
Patil P, Elem B, Zumla A: Pattern of adult malignancies in Zambia (1980–1989) in the light of the human immunodeficiency virus type 1 epidemic. J Trop Med Hyg 98:281–284, 1995
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: IARC Monographs on the Evaluation of Carcinogenic Risks for Humans from the Human Papillomaviruses. Vol. 64, Lyon, IARC, 1995
Breese PL, Judson FN, Penley KA, et al: Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 22:7–14, 1995
Palefsky JM: Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 8:283–295, 1994
Goldman S, Glimelius B, Nilsson B, et al: Incidence of anal epidermoid carcinoma in Sweden, 1970–1984. Acta Chir Scand 155: 191–197, 1989
Frisch M, Melbye M, Moller H: Trends in incidence of anal cancer in Denmark. Br Med J 306:419–422, 1993
Melbye M, Coté TR, Kessler L, et al: High incidence of anal cancer among AIDS patients. Lancet 343: 636–639, 1994
Melbye M, Rabkin C, Frisch M, et al: Changing patterns of anal cancer incidence in the United States, 1940–1989. Am J Epidemiol 139: 772–780, 1994
Rabkin CS, Biggar RJ, Horm JW: Increasing incidence of cancers associated with the Human Immunodeficiency Virus epidemic. Int J Cancer 47:692–696, 1991
Serraino D, Boschini A, Carrieri P, et al: Cancer risk among men with, or at risk for, HIV infection in southern Europe. AIDS submitted
Vaccher E, Tirelli U, Spina M: Lung cancer in 19 patients with HIV infection. Ann Oncol 4:85–86, 1993
Parker MS, Leveno DM, Campbell TJ, et al: AIDS-related bronchogenic carcinoma: fact or fiction? Chest 113:154–161, 1998
Monfardini S, Vaccher E, Pizzocaro G, et al: Unusual malignant tumours in 49 patients with HIV infection. AIDS 3: 449–452, 1989
Newton R, Beral V, Weiss RA: Human Immunodeficiency Virus infection and cancer. In: Newton R, Beral V, Weiss RA (eds): Infections and Human Cancer. Cancer Surveys Vol. 33:237–262, 1999
Newton R, Ziegler J, Mbidde E, et al: HIV and cancer in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol 17: Al2, 1998 (abstr)
Ho DD. Time to hit HIV, early and hard (editorial). N Eng J Med 333: 450–451, 1995.
Feinberg MB, Carpenter C, Fauci AS, et al. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Ann Intern Med 128: 1057–1100, 1998.
Moore RD, Chiasson RE: Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 13: 1933–1942, 1999
Palella FJ, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338: 853–860, 1998
Mocroft A, Vella S, Benfield TL, et al: Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 352: 1725–1730, 1998
Jacobson LP, Yamashita TE, Detels R, et al: Impact of potent antiretroviral therapy on the incidence of Kaposi’s sarcoma and non-Hodgkin’s lymphomas among HIV-1infected individuals. J Acquir Immune Defic Syndr 21(suppl.1): S34–S41, 1999
Rabkin CS, Testa MA, Huang J, et al: Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence trends in AIDS Clinical Trial Group study participants. J Acquir Immune Defic Syndr 21(suppl.1): S31–S33, 1999
Jones JL, Hanson DL, Dworkin MS, et al: Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. J Acquir Immune Defic Syndr 21(suppl.1): S11–S17, 1999
Buchbinder SP, Holmberg SD, Scheer S et al: Combination antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr 21(suppl.1): S23–S26, 1999
Sparano JA, Anand K, Desai J, et al: Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. J Acquir Immune Defic Syndr 21(suppl.1): S18–S22, 1999
Pezzotti P, Dal Maso L, Serraino D, et al: Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments? J Acqui Immune Defic Syndr 20:515–516, 1999
Pezzotti P, Serraino D, Rezza G, et al: The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982–1996. Int J Epidemiol 28:975–981, 1999
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maso, L.D., Serraino, D., Franceschi, S. (2001). Epidemiology of HIV-Associated Malignancies. In: Sparano, J.A. (eds) HIV & HTLV-I Associated Malignancies. Cancer Treatment and Research, vol 104. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1601-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1601-9_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5635-6
Online ISBN: 978-1-4615-1601-9
eBook Packages: Springer Book Archive